A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

Abstract According to the current clinical practice guidelines for chronic obstructive pulmonary disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β2 agonist therapy is recommended in patients with moderate-to-severe disease and an increased risk of exacerbations. However,...

Full description

Bibliographic Details
Main Authors: Marc Miravitlles, Borja G. Cosío, Aurelio Arnedillo, Myriam Calle, Bernardino Alcázar-Navarrete, Cruz González, Cristóbal Esteban, Juan Antonio Trigueros, José Miguel Rodríguez González-Moro, José Antonio Quintano Jiménez, Adolfo Baloira
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Respiratory Research
Subjects:
Algorithm
Chronic obstructive pulmonary disease
Exacerbations
Inhaled corticosteroids
Lung function
Online Access:http://link.springer.com/article/10.1186/s12931-017-0682-y

Internet

http://link.springer.com/article/10.1186/s12931-017-0682-y

Similar Items